UBS Group的 Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share CCV.WS 持股歷史
買進
維持不變
已賣出
持有CCV.WS的其他基金
UBS Group的CCV.WS持股:2023年第4季回顧
UBS Group在2023年第4季出清Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share (CCV.WS)持股,賣出2,443股,估計賣出金額為US$452。
UBS Group首次於2021年第1季申報持有CCV.WS,並持有了8個季度。 這筆持倉在2022年第1季達到US$7,000的高峰。 截至2023年第4季,Wall St. Rank 追蹤的1檔基金持有CCV.WS。
- UBS Group回報,截至2023年第4季已不再持有Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share,因為其在該季度已全數賣出。
- UBS Group在2023年第4季賣出Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share共2,443股,估計金額為US$452。
- UBS Group首次於2021年第1季申報持有Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share,並持有了8個季度。
- UBS Group對Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share的持倉在2022年第1季達到高峰,市值為US$7,000。
- 截至2023年第4季,Wall St. Rank 追蹤的1檔基金持有Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share。
根據UBS Group的2023年第4季 13F申報資料 ,於2024年2月9日提交。